HI SB2276 | 2020 | Regular Session
Status
Spectrum: Moderate Partisan Bill (Democrat 9-1)
Status: Engrossed on March 3 2020 - 50% progression, died in committee
Action: 2020-03-09 - Referred to HLT, CPC, referral sheet 36
Pending: House Health Committee
Text: Latest bill text (Amended) [HTML]
Status: Engrossed on March 3 2020 - 50% progression, died in committee
Action: 2020-03-09 - Referred to HLT, CPC, referral sheet 36
Pending: House Health Committee
Text: Latest bill text (Amended) [HTML]
Summary
Requires drug manufacturers to notify the insurance commissioner, prescription drug benefit plans, and pharmacy benefit managers if a proposed increase in the wholesale price of certain drugs would result in a per cent or more price increase over a twoyear period. Requires the drug manufacturer to identify and report to the insurance commissioner information on certain drugs whose wholesale acquisition cost increases by a certain amount during a specified time frame. Requires the insurance commissioner to post price information on the Department of Commerce and Consumer Affair's website. Imposes fines. Effective 1/1/2050. (SD1)
Title
Relating To Prescription Drugs.
Sponsors
Roll Calls
2020-02-25 - Senate - Senate Judiciary: Passed, Unamended (Y: 3 N: 0 NV: 0 Abs: 2) [PASS]
2020-02-12 - Senate - Senate Commerce, Consumer Protection, and Health: Passed, With Amendments (Y: 5 N: 0 NV: 0 Abs: 2) [PASS]
2020-02-12 - Senate - Senate Commerce, Consumer Protection, and Health: Passed, With Amendments (Y: 5 N: 0 NV: 0 Abs: 2) [PASS]
History
Date | Chamber | Action |
---|---|---|
2020-03-09 | House | Referred to HLT, CPC, referral sheet 36 |
2020-03-05 | House | Pass First Reading |
2020-03-03 | House | Received from Senate (Sen. Com. No. 183) in amended form (SD 1). |
2020-03-03 | Senate | Report adopted; Passed Third Reading. Ayes, 25; Aye(s) with reservations: none . Noes, 0 (none). Excused, 0 (none). Transmitted to House. |
2020-02-28 | Senate | One Day Notice 03-03-20. |
2020-02-28 | Senate | Reported from JDC (Stand. Com. Rep. No. 3135) with recommendation of passage on Third Reading. |
2020-02-25 | Senate | The committee(s) on JDC recommend(s) that the measure be PASSED, UNAMENDED. The votes in JDC were as follows: 3 Aye(s): Senator(s) K. Rhoads, J.Keohokalole, Kim; Aye(s) with reservations: none ; 0 No(es): none; and 2 Excused: Senator(s) Gabbard, Fevella. |
2020-02-21 | Senate | The committee(s) on JDC will hold a public decision making on 02-25-20 12:30PM in conference room 016. |
2020-02-14 | Senate | Report adopted; Passed Second Reading, as amended (SD 1) and referred to JDC. |
2020-02-14 | Senate | Reported from CPH (Stand. Com. Rep. No. 2744) with recommendation of passage on Second Reading, as amended (SD 1) and referral to JDC. |
2020-02-12 | Senate | The committee(s) on CPH recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in CPH were as follows: 5 Aye(s): Senator(s) Baker, S. Chang, Nishihara, L. Thielen, Wakai; Aye(s) with reservations: none ; 0 No(es): none; and 2 Excused: Senator(s) Ruderman, Fevella. |
2020-02-11 | Senate | The committee(s) on CPH deferred the measure until 02-12-20 10:00AM in conference room 229. |
2020-02-07 | Senate | The committee(s) on CPH deferred the measure until 02-11-20 10:15AM in conference room 229. |
2020-01-31 | Senate | The committee(s) on CPH deferred the measure until 02-07-20 9:30AM in conference room 229. |
2020-01-28 | Senate | The committee(s) on CPH deferred the measure until 01-31-20 9:30AM in conference room 229. |
2020-01-24 | Senate | The committee(s) on CPH has scheduled a public hearing on 01-28-20 9:00AM in conference room 229. |
2020-01-21 | Senate | Referred to CPH, JDC. |
2020-01-21 | Senate | Passed First Reading. |
2020-01-17 | Senate | Introduced. |
Subjects
Department of Commerce and Consumer Affairs
Fines
Insurance Commissioner
Notification
Prescription Drugs
Price Increases
Fines
Insurance Commissioner
Notification
Prescription Drugs
Price Increases